Cytogen Corp

Material Contracts Filter

EX-10.1
from 10-Q 8 pages Amendment No. 2 to Product License and Assignment Agreement
12/34/56
EX-10.5
from 10-Q 4 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Asterisks Denote Omissions Amendment No. 1 to Product License and Assignment Agreement
12/34/56
EX-10.5
from 10-Q 10 pages Cytogen Corporation 2004 Non-Employee Director Stock Incentive Plan
12/34/56
EX-10.4
from 8-K 7 pages June 15, 2007 Strictly Confidential
12/34/56
EX-10.3
from 8-K 24 pages Registration Rights Agreement
12/34/56
EX-10.2
from 8-K 17 pages Common Stock Purchase Warrant Cytogen Corporation
12/34/56
EX-10.1
from 8-K 34 pages Securities Purchase Agreement
12/34/56
EX-10.76
from 10-K 24 pages Confidential Materials Omitted and Filed Separately With the Securities and Exchange Commission. Asterisks Denote Omissions
12/34/56
EX-10.75
from 10-K 8 pages Settlement and Release Agreement
12/34/56
EX-10.3
from 8-K 15 pages Registration Rights Agreement
12/34/56
EX-10
from 10-Q ~50 pages Exhibit 10-2 Inpharma Agreement
12/34/56
EX-10.2
from 8-K 14 pages Common Stock Purchase Warrant to Purchase Shares of Common Stock of Cytogen Corporation
12/34/56
EX-10
from 10-Q ~20 pages Exhibit 10-1 Laureate Manufacturing Agreement
12/34/56
EX-10.1
from 8-K 31 pages Securities Purchase Agreement
12/34/56
EX-10
from 10-Q ~20 pages Exh 10.6 Product Purchase and Supply Agreement
12/34/56
EX-10
from 10-Q ~50 pages Exhibit 10.5 M and S Agreement
12/34/56
EX-10
from 10-Q ~50 pages Exhibit 10.4 Exclusive Distribution Agreement
12/34/56
EX-10
from 10-Q ~50 pages Exhibit 10.3 - License Agreement
12/34/56
EX-10
from 10-Q ~20 pages Exhibit 10.2 Purchase Agreement
12/34/56
EX-10
from 10-Q ~20 pages Exhibit 10.1 2006 Equity Compensation Plan
12/34/56